微信公众号
News Center
2020
2022-04-15
![[Technical Sharing] Discussing the Development and Preparation of Monoclonal Antibodies](https://omo-oss-image.thefastimg.com/portal-saas/pg2024072315461374370/cms/image/dd2ed157-71f3-4cf5-b9ab-25fe5bd204ca.png "[Technical Sharing] Discussing the Development and Preparation of Monoclonal Antibodies")
[Technical Sharing] Discussing the Development and Preparation of Monoclonal Antibodies
With the continuous maturation of antibody production technology, monoclonal antibody reagents and drugs will undoubtedly bring greater hope to patients worldwide.
Learn More Details
2022-04-04
![[Lung Cancer Report] Understand the powerful tools against cancer in 3 minutes by looking at the data](https://omo-oss-image.thefastimg.com/portal-saas/pg2024072315461374370/cms/image/6b6f63a6-6433-4c68-b2a8-17e95c67a725.png "[Lung Cancer Report] Understand the powerful tools against cancer in 3 minutes by looking at the data")
An increasing number of methylation molecular markers are being explored and discovered for the early diagnosis and differential diagnosis of various cancers such as lung cancer. At the same time, research and development on more diverse sample types are continuously underway, paving the way for early non-invasive tumor detection.
Learn More Details
2022-03-29
JNCC Major Announcement! Academician He Jie’s Team Releases the Latest Cancer Data in China
Academician He Jie is the corresponding author of an article titled "Cancer Incidence and Mortality in China, 2016" published in JNCC. This study is based on the latest data from the National Cancer Center, selecting 487 high-quality monitoring sites from 682 cancer surveillance points nationwide, covering a population of 380 million, and provides a detailed account of the cancer disease burden in China in 2016.
Compared with 2015, the number of reporting monitoring sites increased by 181, and the number of high-quality monitoring sites increased by 119, indicating that the coverage of tumor registration work in our country is gradually advancing, and the data quality and standardization have further improved, providing stronger scientific evidence for the formulation of national health policies.
Learn More Details
2022-03-28
![[Indicator Interpretation] The Expression Role of Ki-67 in Different Tumors (Part 2)](https://omo-oss-image.thefastimg.com/portal-saas/pg2024072315461374370/cms/image/c097015e-123a-44e5-86dd-32d65e70f3d2.jpg "[Indicator Interpretation] The Expression Role of Ki-67 in Different Tumors (Part 2)")
[Indicator Interpretation] The Expression Role of Ki-67 in Different Tumors (Part 2)
In the pathological diagnosis process of cancer lesions, implementing immunohistochemical testing for patients can improve diagnostic and differential accuracy, has significant clinical value, and deserves our attention and promotion.
Learn More Details
2022-03-09
The Fifth Session of the 13th National People's Congress has opened. As a deputy to the National People's Congress, Yan Dapeng, Deputy Secretary of the Party Committee, Vice Chairman, and Chief Engineer of Raycus Laser, submitted a proposal to the congress this year regarding further support for the procurement of domestically produced equipment and instruments.
Learn More Details
2022-03-08
![[CaltBio Immunology Class Issue 01] Common Problems and Solutions in Immunohistochemistry | A Must-Read for Beginners](https://omo-oss-image.thefastimg.com/portal-saas/pg2024072315461374370/cms/image/0d71e7c0-fc2f-4879-a350-e4c6df477262.jpg "[CaltBio Immunology Class Issue 01] Common Problems and Solutions in Immunohistochemistry | A Must-Read for Beginners")
Immunohistochemistry (IHC) has a significant impact on tumor diagnosis, tumor classification, and prognosis assessment. It also expands our understanding of various diseases and tumor formation processes, enhancing the level of pathological diagnosis and research.
Learn More Details